Legend Biotech Corp.

NASDAQ:

LEGN

Legend Biotech Corp. welcomes the opportunity to reinvigorate the treatment approaches in oncology and the future of cell therapy. Today, Legend Biotech's research is focused on continuous innovation in the field of cell therapy. Legend Biotech is also future focused on emerging technologies that can help address some of the most chronic and life-threatening diseases.

Key Facts

Auditor

Public Listing

Domicile

HQ/Management

Location of Key Operations

IR Contact

Ernst & Young LLP

IPO (June 5, 2020)

Cayman Islands

Somerset, NJ, USA

Jessie Yeung, Internal

Analyst Coverage

Latest News